The Lancet: mRNA疫苗產生比科興滅活疫苗多10倍抗體

CNBC:BioNTech (BNTX) – A study published in the medical journal The Lancet showed that BioNTEch’s mRNA-based Covid-19 vaccine produced 10 times more antibodies than the inactivated virus-based vaccine produced by China’s Sinovac. BioNTech rose 1.7% in premarket trading.

 

https://www.cnbc.com/2021/07/16/stocks-making-the-biggest-moves-premarket-moderna-didi-biontech-amc-and-others.html?recirc=taboolainternal